MedTrace Logo

Vasopressin Deficiency in Hemorrhagic Shock

NCT01107314 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2018-01-17

No results posted yet for this study

Summary

In this study we hope to delineate the typical vasoactive mediator response of trauma patients to shock. We plan to assess serum levels of vasopressin and also catecholamines, angiotensin, and cortisol during resuscitation of trauma patients to delineate high risk populations for vasopressin deficiency.

Conditions

  • Body Response to Trauma

Interventions

OTHER

Phlebotomy

Blood draws (total 48 cc blood)

Sponsors & Collaborators

  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Principal Investigators

  • Stephen M Cohn, MD · The University of Texas Health Science Center at San Antonio

Eligibility

Min Age
18 Years
Max Age
98 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01107314 on ClinicalTrials.gov